Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study.
Saved in:
| Title: | Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study. |
|---|---|
| Authors: | Bissonnette, R.1 rbissonnette@innovaderm.ca, Haydey, R.2, Rosoph, L. A.3, Lynde, C. W.4, Bukhalo, M.5, Fowler, J. F.6, Delorme, I.7, Gagné‐henley, A.8, Gooderham, M.9, Poulin, Y.10, Barber, K.11, Jenkin, P.12, Landells, I.13, Pariser, D. M.14 |
| Source: | Journal of the European Academy of Dermatology & Venereology. Mar2018, Vol. 32 Issue 3, p403-410. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
